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Drug-induced changes in the functional properties of neurons in the mesolimbic
dopaminergic system are attractive candidates for the molecular underpinnings of
addiction. A central question in this context has been how drugs of abuse affect synaptic
plasticity on dopaminergic cells in the ventral tegmental area. We now know that the
intake of addictive drugs is accompanied by a complex sequence of alterations in the
properties of excitatory synapses on dopaminergic neurons, mainly driven by signaling
and redistribution of NMDA- and AMPA-receptors. It has, however, been unclear how
these molecular changes are related to the behavioral effects of addictive drugs. Recently,
new genetic tools have permitted researchers to perform genetic intervention with
plasticity-related molecules selectively in dopaminergic cells and to subsequently study
the behaviors of genetically modified mice. These studies have started to reveal how
plasticity and drug-induced behavior are connected as well as what role plasticity in
dopaminergic cells may have in general reward learning. The findings thus far show that
there is not a one-to-one relation between plastic events and specific behaviors and that
the early responses to drugs of abuse are to a large extent independent of the types of
synaptic plasticity so far targeted. In contrast, plasticity in dopaminergic cells indeed is an
important regulator of the persistence of behaviors driven by drug associations, making
synaptic plasticity in dopaminergic cells an important field of study for understanding the
mechanisms behind relapse.
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INTRODUCTION
The intake of drugs of abuse initiates progressive molecular
changes in different parts of the brain. Whereas, some of these
changes are associated with addiction, others relate to physiolog-
ical or behavioral phenotypes that are not critically involved in
the development of persistent drug-induced behaviors. However,
distinguishing the changes associated with addiction from those
merely correlated with drug intake has remained a challenge.
Here, we focus on drug-induced synaptic strengthening of exci-
tatory synapses on dopaminergic cells, a drug-induced change
identified with electrophysiological techniques, and discuss how
modern genetic intervention techniques have been used to elu-
cidate the function of such plasticity. First, we will provide a
brief summary of the genetic tools used, highlighting their pros
and cons, and subsequently, we will discuss results from studies
in which they have been used to assay the function of synaptic
plasticity on dopaminergic cells, both in the context of cocaine
addiction as well as in the setting of natural motivated behaviors.
THE GENETIC TOOLBOX
Methods employed in the generation of genetically modified
mice may be categorized based on the approach to introduce
the mutation. The first approach is the replacement of a spe-
cific sequence in the genome by another, known as homologous
recombination. This method involves transfection of embryonic
stem cells with a DNA construct harboring a fragment that will
replace the endogenous sequence flanked by homologous target-
ing sequences. The cells with recombined target sequence are then
injected into mouse embryos in the blastocyst stage and trans-
ferred into a foster mother. Some of the offspring will be able
to transmit the mutation, thus “founding” the mutated strain.
This is the strategy employed in the generation of knockout
(“KO”) animals. It also allows for the introduction of special
sequences such as loxP sites to intronic regions flanking critical
parts of a gene (a “floxed” gene) (Abremski et al., 1983; Thomas
and Capecchi, 1987; Gu et al., 1994). Homologous recombi-
nation is also used to replace parts of a gene with another
sequence (a so called “knockin”) such as a recombinase. Until
recently, it was only possible to produce embryonic stem cells
from specific mouse strains, such as 129 or FVB. Thus, many
“KO” or “flox” lines have mixed strain background if they were
not back-crossed over several generations. This may occasionally
be a confounding factor, considering the differences in behav-
ioral phenotypes of the 129 vs. C57 strains and, in particular,
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their different sensitivities to reinforcement and learning abilities
(Crabbe et al., 2010).
A second approach involves random insertion of a new
DNA fragment (i.e., a transgene) in the genome. This is
achieved by injecting a DNA construct into the prozygote
(pronuclear injection) upon which a fraction of the offspring
born from injected embryos will carry the transgene randomly,
but stably, as it has been incorporated into their genome. This
method has numerous applications (Branda and Dymecki, 2004;
Dymecki and Kim, 2007). It is frequently used to introduce the
Cre recombinase, an enzyme derived from bacteriophage P1,
which belongs to the family of topoisomerases and has the abil-
ity to cut and ligate DNA strands (Abremski et al., 1983). Cre
recognizes specific sequences, the loxP sites, which are not nor-
mally present in the murine genome. When a mouse with a
recombinase transgene under the control of a cell-type specific
promoter is crossed with an animal that contains a gene con-
taining loxP sequences (created by homologous recombination),
a deletion in the target gene will occur only in Cre-expressing
cells (see Figures 1, 2). For mouse lines generated by pronu-
clear injection, the milieu surrounding the site of integration
may affect both the level of transgene transcription as well as the
cell-type specificity of expression. This may be circumvented in
most cases by introducing large transgenes (over 100,000 DNA
bases) based on bacterial artificial chromosomes (BACs) in which
long flanking sequences buffer the positional effects (Yang et al.,
1997).
For studies on the functional role of plasticity in dopamin-
ergic cells, it is of pivotal importance to be able to delete genes
selectively in dopaminergic cells. This is typically performed with
mouse lines expressing the Cre recombinase under the control
of the promoter of the dopamine transporter (DAT), also called
Slc6a3. The strategies employed differ considerably. The knock-in
approach in which the Cre sequence is replacing one DAT allele
was used to generate one of the frequently used strains (Zhuang
et al., 2005; Zweifel et al., 2008). This approach is advantageous in
that it typically offers high fidelity in the pattern of recombinase
expression (i.e., only in dopaminergic cells). However, removing
one allele of a gene is sometimes sufficient to produce a change
in behavior or physiology, as indeed was reported in the case
of DAT (Jones et al., 1998). In a second line, this problem was
avoided by introducing the Cre recombinase after the DAT encod-
ing sequence, separated by an IRES sequence to allow translation
of both the DAT and the Cre sequence (Backman et al., 2006).
In another mouse line, Cre was expressed from a large trans-
gene (Parlato et al., 2006), as well as also using the CreERT2
modification (Rieker et al., 2011), which prevents recombination
until animals are treated with the synthetic steroid tamoxifen (Feil
et al., 1996; Engblom et al., 2008) (Figure 1). Finally, Cre has also
been targeted to regions with dopaminergic cells using stereotaxic
injection of viral vectors (Zweifel et al., 2008), thus limiting the
recombination to cells infected by the virus. This method allows
targeting of very precise brain areas with the mutation (i.e., only
VTA instead of all DAT-expressing cells in the body). However,
this approach is often limited by problems with recombination
efficiency and limited selectivity (i.e., all neuron types instead of
only DAT-expressing).
The reported efficiency of recombination by the DAT-driven
Cre recombinases was excellent, affecting essentially all dopamin-
ergic cells (Engblom et al., 2008; Zweifel et al., 2008; Luo et al.,
2010; Rieker et al., 2011). Nevertheless, it was also reported that
the offspring of an animal carrying the transgene and one floxed
allele of the target gene would frequently show complete dele-
tion of the allele (/flox; so-called “germline” recombination).
This could be due to transient activity of the DAT promoter dur-
ing very early development or gamete formation. The frequency
of such events was reported to be highest in mice where the Cre
replaces one of the DAT alleles. To prevent the germ-line deletion
from confounding the behavioral analyses, additional genotyping
is performed to remove affected mice or control groups includ-
ing heterozygous animals (i.e.,/flox without the Cre transgene)
are added to the experimental design. Moreover, scattered Cre-
mediated recombination is sometimes observed in brain areas not
expressing DAT, as even transient activity of the transgene may be
sufficient to drive the mutation. This type of activity has accu-
mulating effects with age, often being more pronounced in older
animals.
In plasticity studies, dopamine cell-specific deletions have
mostly targeted NMDA receptors. These studies are based on
partial deletions of the gene encoding the essential NR1 recep-
tor subunit (Grin1) using modified variants of the gene with
loxP sequences introduced in introns after exons 10 and 18
(Niewoehner et al., 2007), 10 and 23 (Zweifel et al., 2008), or 11
and 21 (Tsien et al., 1996). Deletion of molecules that are central
for neural signaling, such as NMDARs, may cause compensatory
changes in the activity of targeted neurons due to the recombi-
nation occurring early in the development of the neurons. In the
case of the Cre/loxP-mediated ablations of NR1 in dopaminergic
cells, which has already occurred in the second week of embryonic
development, the mutation caused an increase in spontaneous
activity of dopaminergic cells measured in slice preparations
(Engblom et al., 2008; Zweifel et al., 2008). This problem could
be circumvented by the use of the inducible CreERT2 variant pre-
viously described. However, as with all approaches described in
this section, this method is not without pitfalls. First, so-called
“leakiness,” a level of recombination occurring without tamoxifen
treatment, is a frequent problem. Second, tamoxifen treatment
requires multiple i.p. injections over several days and is stressful to
the animal, possibly causing persistent changes in behavior (Vogt
et al., 2008).
In conclusion, although genetic intervention is an elegant way
to test a gene’s association with a specific phenotype, no method
is without caveats. The discrete differences between superficially
similar approaches should not be discarded as a technical aspect
irrelevant to the conclusions. Inference of associations between
genes and phenotypes is not possible without very extensive and
sometimes impractical control experiments. In fact, it is simpler
to demonstrate that a gene is not essential to a specific phenotype.
Unfortunately, this is often avoided or unreported.
SYNAPTIC PLASTICITY IN DOPAMINERGIC CELLS
Synaptic plasticity, such as, long-term potentiation and long-term
depression has received much attention since they may constitute
cellular substrates of learning and memory (Malenka and Bear,
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FIGURE 1 | Deletion of loxP flanked sequences by the Cre recombinase.
A fragment of the NR1 (Grin1) gene is shown as a line with solid black
rectangles representing exons. The numbers above the rectangles
correspond to exons. The two triangles represent the loxP sequences
introduced in introns, placed in the same orientation and flanking exons 11–18
(Niewoehner et al., 2007). The Cre recombinase has a nuclear localization
signal and is normally shuttled to the nucleus after translation, where it
catalyzes a deletion of the gene fragment flanked by the loxP sites. Thus,
gene inactivation will occur soon after the gene promoter driving Cre
expression becomes active, typically around the 13th day of embryonic
development (Parlato et al., 2006). The CreERT2 is a fusion protein of the Cre
and a modified ligand binding domain of the estrogen receptor (ERT2). The
modification prevents binding of endogenous estrogens but allows binding of
tamoxifen, a synthetic steroid (represented by a circle with a “T”).
Additionally, the presence of the ERT2 domain enables interaction with the
mechanisms normally responsible for keeping the estrogen receptor in the
cytosol, in particular interaction with Hsp90. Binding of tamoxifen to the
ERT2 releases its interaction with the cytosolic proteins and permits shuttling
to the nucleus, where it catalyzes the deletion of the gene fragment flanked
by loxP sequences.
2004). Because aberrant reward learning has been proposed to be
a key feature of drug addiction, drug-induced synaptic plasticity
is a strong candidate for being critical for the development and
persistence of addiction and other related behavioral responses to
drugs of abuse (Everitt et al., 2001; Hyman et al., 2006; Luscher
and Malenka, 2011). Given the pivotal role of dopaminergic cells
in the rewarding actions of addictive drugs, these cells were a
natural starting point in the search for drug-induced synaptic
alterations. In a landmark study, Ungless et al. (2001) showed
that a single injection of cocaine leads to a strengthening of exci-
tatory synapses on dopaminergic cells of the ventral tegmental
area, measured as an increase in the AMPA/NMDAR ratio in slices
from the midbrain of mice (Figure 3). Later on, it was shown
that all major addictive drugs can induce the same adaptation
and that it is also induced by stress and reward-predicting cues
(Saal et al., 2003; Stuber et al., 2008). The synaptic strengthen-
ing lasts for approximately 5 days after a single passive injection
of cocaine (Ungless et al., 2001) and at least 3 months after a
period of cocaine self-administration (Chen et al., 2008). Given
the relatively limited life span of the rat, this is a very persistent
change and is therefore interesting from a clinical perspective. A
schematic representation of main excitatory and inhibitory inputs
to the VTA is shown in Figure 4.
On the molecular level, it seems that everything that leads
to increased dopamine levels in the VTA triggers the synaptic
strengthening. Such increases are due to the dendritic release of
dopamine from the dopaminergic cells and can be triggered by an
increased firing rate of the dopaminergic cells, which is sufficient
for the synaptic plasticity to occur, as shown by an optogenetic
approach (Brown et al., 2010), or through the local release of
dopamine due to interference with catecholamine transporters
in the VTA (Argilli et al., 2008). Thus, we know that cocaine
administered to midbrain slices induces synaptic strengthening
and that administration of a D1/D5 receptor antagonist, as well as
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FIGURE 2 | Deletion of NMDA receptors selectively in dopaminergic
cells.
the deletion of the D5 receptor, blocks the strengthening (Argilli
et al., 2008). Because midbrain dopaminergic neurons express
D5 but not D1 receptors (Khan et al., 2000), the dopamine
action is most likely mediated by D5 receptors on dopamine
neurons, although a role for D1 receptors on afferents contact-
ing the dopaminergic cells cannot be ruled out. In any case,
NMDA receptors are necessary for the plasticity. Because dele-
tion of NMDA receptors selectively on dopaminergic cells in adult
mice is sufficient to block the strengthening (Engblom et al., 2008;
Zweifel et al., 2008), we know that this is due to the disruption
of NMDAR signaling on the dopaminergic cells themselves and
that it is unlikely that the loss of plasticity is explained by adapta-
tions during development. Further, the AMPA receptor subunit
GluR1, located on the dopaminergic neurons, is necessary for
the plasticity (Dong et al., 2004; Engblom et al., 2008). Careful
studies of the induction mechanism strongly indicate that drugs
trigger the release of dopamine, indirectly leading to NMDAR
activation on dopaminergic cells. This in turn leads to the redis-
tribution of AMPA receptors so that receptors containing the
subunit GluR2 are exchanged for receptors that do not (e.g.,
GluR1 homotetramers) (Bellone and Luscher, 2006) (Figure 3).
These receptors have a higher conductance and are permeable to
calcium, and their incorporation leads to an increased respon-
siveness and also changes the rules for further strengthening at
the synapse (Mameli et al., 2011). The AMPA receptor redis-
tribution is accompanied by a reduction in functional NMDA
receptors at the synapse (Mameli et al., 2011). If drug use is dis-
continued, an mGluR1-dependent mechanism resets the synapse
to the original setup after around 1 week (Mameli et al., 2007).
In addition to changing the receptive properties of the dopamin-
ergic cell, this plasticity triggers plastic events in the nucleus
accumbens (Mameli et al., 2009). The role of drug-induced
synaptic adaptations in this structure has been reviewed else-
where (Thomas et al., 2008; Wolf, 2010; Luscher and Malenka,
2011).
To describe synaptic strengthening at these synapses as a
unified phenomenon is, of course, somewhat simplistic. The
dopaminergic cells in the VTA receive input from many differ-
ent structures (Figure 4) and have different projections. Thus
far, very little is known about how connectivity affects plastic-
ity in these cells, but dopaminergic neurons projecting to the
cortex have been shown to be molecularly distinct from neu-
rons projecting to the nucleus accumbens and are known to
react with synaptic strengthening in response to aversive rather
than rewarding stimuli (Lammel et al., 2011). Complicating mat-
ters even further, the synaptic strengthening described above
is not the only form of drug-induced synaptic plasticity in
dopaminergic cells. Of particular interest for the interpreta-
tion of functional studies addressing the role of the synap-
tic strengthening is the form of plasticity called LTP-GABA
(Nugent et al., 2007). This plasticity is NMDAR-dependent
and increases the release of GABA from terminals contacting
the dopaminergic cells. Interestingly, morphine, cocaine, and
nicotine inhibit LTP-GABA (Nugent et al., 2007). A postsy-
naptic form of GABA plasticity, leading to weaker inhibitory
transmission, has also been described after repeated cocaine
exposure (Liu et al., 2005; Pu et al., 2006). Although, much
less is known about these forms of inhibitory plasticity, it is
important to keep them in mind when interpreting studies
that intervene in the functioning of plasticity-related molecules
in dopaminergic cells because, to some extent, they share
mechanisms.
FUNCTIONAL STUDIES USING GENETIC TOOLS
As previously noted, a lot of drug-induced molecular changes
have no impact on behavior, and because addiction is a behavioral
disorder, it is of pivotal importance to understand how differ-
ent forms of synaptic plasticity contribute to behavior. However,
this task is not trivial, and the different approaches used all
have their weaknesses. One source of information is classical
pharmacological studies in which NMDA or AMPA receptor
antagonists are injected into the VTA. These studies indicate
that NMDARs and AMPA receptors in the VTA are essential
for both cocaine-induced behavioral sensitization (Kalivas and
Alesdatter, 1993) and conditioned place preference (Harris and
Aston-Jones, 2003). However, the problem with these studies is
that they also target non-dopaminergic cells in the VTA and
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FIGURE 3 | Drug-induced synaptic strengthening of excitatory synapses on dopaminergic neurons.
that the effects observed are not necessarily due to inhibited
plasticity as they could be due to the disruption of steady state
signaling. Thus, the results could imply that NMDAR signaling
in response to the drug is necessary for triggering some type
of adaptation that is essential for sensitization, but this change
could be something completely different from synaptic strength-
ening on dopaminergic neurons. In this context, an important
technical addition was the use of rats with viral mediated overex-
pression of GluR1 in the VTA (Carlezon et al., 1997). These rats
should have synapses that are inherently strengthened. Indeed,
they showed an increase in the locomotor activity in response
to an acute injection of morphine, indicating that they were
in a pre-sensitized state. Additionally, these animals displayed a
potentiated CPP to morphine (Carlezon et al., 1997). Recently,
it was also shown that such rats show increased motivation for
self-administration of cocaine (Choi et al., 2011). The main prob-
lem with this type of study is that the forced overexpression of
GluR1 is not physiological. To an extent, this has been solved
by loss-of-function approaches using mice lacking GluR1. In
these mice, the basal properties of the excitatory transmission on
dopaminergic cells seem to be relatively unaltered—most likely
due to the function of GluR3 compensating for the lack of GluR1.
However, the synaptic strengthening is blocked in GluR1 KOmice
(Dong et al., 2004), showing that GluR3 cannot compensate for
GluR1 in this aspect. Interestingly, the GluR1 KO mice formed
a perfectly normal sensitization to cocaine, whereas conditioned
place preference was affected in one study (Dong et al., 2004) but
not in others (Mead et al., 2005; Engblom et al., 2008). The major
limitation of this approach is that it is impossible to know if an
effect on behavior is due to the lack of GluR1 in dopaminergic
cells or elsewhere. This is not only a theoretical problem because
a priori, it would seem quite likely that GluR1-mediated plastic-
ity in the nucleus accumbens, the amygdala or the hippocampus
would be involved in reward-learning-related behaviors. Recent
studies using Cre/loxP methodology have added some missing
pieces to this puzzle, although the results are not always easy
to fit into a coherent picture. Importantly, some of these stud-
ies also looked beyond the early drug-induced behaviors using
relapse models. In one study (Engblom et al., 2008), mice with
deletions of GluR1 (GluR1-DATCre), GluR2 (GluR2-DATCre),
or NMDARs (NR1-DATCre) specific to dopamine neurons were
used. The fact that the deletions are selective to dopaminer-
gic cells is important since the aim was to investigate the role
of plasticity in these specific cells but also since mice lacking
NMDARs in the entire body die within the first day after birth
(Forrest et al., 1994). As expected, cocaine-induced strengthen-
ing of excitatory synapses on dopaminergic cells was blocked in
mice lacking GluR1 or NMDARs on dopaminergic cells, whereas,
this effect was intact in mice lacking GluR2. Intriguingly, mice
lacking GluR1 or NMDARs showed perfectly normal locomo-
tor sensitization and CPP, indicating that the synaptic strength-
ening is not important for these early drug effects (Engblom
et al., 2008). In contrast, mice lacking GluR1 in dopaminergic
cells showed a blocked extinction of the CPP, and mice lack-
ing NMDARs in dopaminergic cells showed a normal extinction
but a blocked drug-induced reinstatement of the CPP. In addi-
tion, when NMDARs were deleted in dopaminergic cells of adult
mice, to avoid the synaptic scaling induced by early removal
of NMDARs, an identical block of reinstatement was observed.
The inducible NMDARmouse line (NR1-DATCreERT2) was later
also used in a self-administration paradigm, the results of which
were compatible with a role of NMDARs in dopaminergic cells
in relapse (Mameli et al., 2009). In this case, the mutant mice
showed normal levels of cocaine self-administration and normal
extinction behaviors but reduced cue-induced reinstatement of
cocaine-seeking. Thus, although there are also conflicting results
(Luo et al., 2010), both of these studies are compatible with the
view that NMDAR-dependent synaptic plasticity on dopaminer-
gic cells is important for the persistence of drug seeking rather
than the early responses to cocaine. Intriguingly, in another study,
Zweifel et al. found a blockade of cocaine CPP in mice with
deletion of NMDARs in dopaminergic cells (NR1-DATCre) and
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FIGURE 4 | Afferents to the ventral tegmental area (VTA). On the
diagram, origins of the main excitatory inputs are shown as blue circles,
origins of the main inhibitory inputs as yellow circles, and the VTA and
substantia nigra (SN) as red circles. Excitatory inputs originate from the
prefrontal cortex (PFC), periaqueductal grey (PAG), the pedunculopontine
nucleus (PPN), the laterodorsal tegmentum (LTG), lateral hypothalamus
(LHA), lateral preoptic area (LPOA) and the reticular formation (Rt). The
subthalamic nucleus (STH) was reported to send projections to the SN
but not the VTA. It should be noted that the excitatory projections are
forming synapses not only on dopaminergic cells, but on other types of
neurons present in the VTA as well. GABAergic signaling regulates the
activity of the VTA, both through local inhibitory neurons as well as
afferents coming from the nucleus accumbens septi (NAc), ventral
pallidum (VP), globus pallidus (GP), amygdaloid nuclei (Amy) and the
mesopontine rostromedial tegmental nucleus. Additionally, a fraction of
the afferents from the PPN was found to be GABAergic. The diagram
does not show all inputs to the VTA, notably omitting serotonergic and
cholinergic afferents and also inputs to non-dopaminergic neurons. For an
excellent review of the architecture of the mesolimbic system please see
Sesack and Grace (2010).
in mice with a local deletion of NMDARs in the VTA using a
viral approach (Zweifel et al., 2008). The latter could be due to
an effect on non-dopaminergic cells because NMDARs on non-
dopaminergic cells in the VTA have been shown to regulate other
cocaine-induced responses (i.e., locomotor sensitization) (Luo
et al., 2010), but the blocked CPP in the NR1-DATCre mice at
first glance contrasts sharply with the unaffected CPP observed
by Engblom et al. and another study using different mouse lines
(Luo et al., 2010). The differing results might reflect the fact that
Zweifel et al. used mice with knockin-based Cre expression, thus
destroying one of the DAT loci, and with heterozygous global
deletion of NR1, both of which are known to affect behavior.
Another possible reason is that in the CPP procedure used by
Zweifel et al., every conditioning is followed by a drug-free test,
mimicking an extinction session andmaking the subsequent con-
ditioning quite similar to a reinstatement session. Thus, the CPP
protocol used by Zweifel et al. actually has similarities to the
reinstatement protocol used by Engblom et al., possibly indicat-
ing a reason for the deficiency observed in these two tests. Thus,
it is quite clear from these studies that NMDARs in dopamin-
ergic cells are not a universal requirement for cocaine CPP, but
the findings of Zweifel et al. together with data on natural reward
learning (discussed later) and nicotine CPP (Wang et al., 2010)
indicate that it may be important for some associations under
specific conditions.
Collectively (summarized in Figure 5), the most solid con-
clusion from these studies seems to be that for cocaine,
NMDAR-dependent signaling in dopaminergic cells is important
in reinstatement of both CPP and self-administration, indicating
a possible role in relapse. However, we know very little about the
mechanisms behind this involvement. For example, we do not
know at which stage they are required. Along this line, we also
do not know if the blocked reinstatement has anything to do with
the fact that drug-induced synaptic strengthening is blocked. It
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FIGURE 5 | Changes in cocaine-related behaviors in mice with deletions of NMDARs or GluR1. Studies: 1, Engblom et al. (2008); 2, Zweifel et al. (2008);
3, Luo et al. (2010); 4, Mameli et al. (2009); 5, Dong et al. (2004); and 6, Mead et al. (2005). SA, Self administration.
could be that impaired LTP-GABA explains the lack of reinstate-
ment or even that NMDAR signaling is required only during the
reinstatement procedure and has a role unrelated to any plas-
ticity. Moreover, as will be discussed later on, the mice lacking
NMDARs in dopaminergic cells have also been used as a model
to study a lack of burst firing, another potentially important phe-
nomenon in the context of reinstatement. Unfortunately, because
the GluR1-DATCre mice showed a blocked extinction, it was not
possible to determine if they reinstate, which would have provided
strong support for the idea that deficiencies in synaptic strength-
ening in dopaminergic cells are responsible for relapse. Thus,
we cannot, at the present stage, prove any one-to-one correla-
tion between synaptic strengthening and a behavioral phenotype,
which may not be surprising given how difficult it has been
to determine the relation of other even more well-characterized
types of plasticity. Nevertheless, the data clearly point to a role for
synaptic strengthening in the persistence of cocaine seeking, even
if the exact mechanism remains partly unclear.
THE ROLE OF NMDARs ON DOPAMINERGIC CELLS IN
MOTIVATED BEHAVIORS
It was observed that inactivation of NMDARs diminished burst
(phasic) firing of DA neurons, without notably altering tonic
activity (Zweifel et al., 2009; Wang et al., 2011). The scaling of
excitatory synapses on DA neurons in mutant mice had no signif-
icant effect on dopamine tissue or extracellular levels (Engblom
et al., 2008; Zweifel et al., 2008, 2009, 2011; Mameli et al., 2009).
Hence, the mutant mice are an excellent model to distinguish
the roles of tonic and burst activity in learning and motivated
behaviors. Indeed, loss of NMDARs on dopamine neurons did
not influence several behaviors that are known to depend on tonic
dopamine signaling. NMDAR loss did not alter novelty-induced
locomotor activity and recognition of a novel object, food con-
sumption when chow is available ad libitum, social behaviors or
prepulse inhibition (Zweifel et al., 2009). Mutant mice had nor-
mal learning abilities, as indicated by a normal latency to find a
hidden platform in the Morris water maze and an intact ability
to navigate in a T-maze task (Zweifel et al., 2009). Strikingly, loss
of NR1 on dopaminergic cells did not affect acquisition of the
conditioned approach during Pavlovian training (Parker et al.,
2010), a behavior that was shown to involve phasic activity of
dopamine cells and NMDAR-dependent synaptic-plasticity in the
VTA (Stuber et al., 2008). Despite the lack of phasic activity
mutant mice responded to the presentation of a cue previously
signaling delivery of a reward, and presentation of the cue elicited
dopamine release similar to that observed in control mice.
Conversely, the lack of burst-firing of dopamine neurons in
mutant mice impaired their performance in several tasks depen-
dent on salient cues or contexts, which included the cued water
maze and T-maze tasks as well as fear-potentiated acoustic star-
tle (Zweifel et al., 2009). They were also slower to learn the
instrumental task in food self-administration but showed simi-
lar motivation to obtain food as assessed by the progressive ratio
test, where the number of instrumental responses necessary to
obtain a food reward increases with each reward administered
(Zweifel et al., 2009). Nevertheless, in other mouse strains with
an equivalent ablation of NMDAR in dopamine cells no impair-
ment in learning of an instrumental task rewarded with cocaine
(Mameli et al., 2009) or food (Wang et al., 2011) was reported.
To some extent these discrepancies could be explained by a deficit
Frontiers in Molecular Neuroscience www.frontiersin.org August 2012 | Volume 5 | Article 89 | 7
Rodriguez Parkitna and Engblom Drugs and plasticity of dopaminergic neurons
of habit learning observed in mutant mice (Wang et al., 2011),
which could affect their performance in tests with large num-
bers of repeated trials. Furthermore, differences in sensitivity to
food vs. drug rewards were also observed in other behavioral tests.
Mutant mice were found to have attenuated food CPP (Zweifel
et al., 2009), even though most studies show that they develop
a normal cocaine CPP (Engblom et al., 2008; Luo et al., 2010).
Finally, the loss of NMDARs caused increased susceptibility to
prolonged stress effects, as indicated by a persistently increased
acoustic startle response and more anxiety-like behavior in the
elevated plus maze test after aversive conditioning in mutant ani-
mals compared to controls (Zweifel et al., 2011). This phenotype
could be prevented by injection of a viral vector that restored NR1
expression in dopamine cells, thus suggesting that impaired burst
activity of VTA neurons may be involved in the development of
anxiety disorders.
CONCLUSION
Reports on behavioral phenotypes of mice with selective NR1
ablation in dopamine cells show selective roles of NMDA receptor
plasticity and burst firing activity in reward learning. Many
behaviors previously presumed to be associated with NMDA
receptor-dependent long-term potentiation in dopamine neu-
rons, such as, drug-conditioned place preference, psychomo-
tor sensitization, or drug self-administration, are normal or
mildly altered in mutant mice. Conversely, the loss of func-
tional NMDA receptors prevented reinstatement of cocaine-
conditioned place preference, attenuated reinstatement of cocaine
self-administration and also generally impaired behaviors depen-
dent on salient cues or contexts. Thus, despite differences in
reported phenotypes, a possible conclusion is that NMDA recep-
tors on dopamine cells are involved in the recall of previously
learned behaviors in response to salient stimuli.
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